CARDIOZYME CK-CONTROL ABNORMAL— 510(k) K770971

Substantially Equivalent

Dade, Baxter Travenol Diagnostics, Inc.

FDA 510(k) clearance K770971 for CARDIOZYME CK-CONTROL ABNORMAL, Substantially Equivalent on 1977-08-04. Applicant: Dade, Baxter Travenol Diagnostics, Inc..

Clearance details

Applicant: Dade, Baxter Travenol Diagnostics, Inc.
Product code: Code JJT
Advisory panel: Clinical Chemistry
Date received: 1977-05-31
Decision date: 1977-08-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.